Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCisplatinDoxorubicinCombined Modality TherapyCyclophosphamideTreatment OutcomeNeoplasmsEtoposideBreast NeoplasmsCell Line, TumorNeoadjuvant TherapyDisease-Free SurvivalDrug Resistance, NeoplasmLung NeoplasmsAntineoplastic Agents, PhytogenicNeoplasm StagingSurvival AnalysisPaclitaxelDrug Screening Assays, AntitumorTime FactorsPhotic StimulationDrug Administration SchedulePrognosisSurvival RateMethotrexateApoptosisCarboplatinVinblastineTaxoidsAntibiotics, AntineoplasticAntimetabolites, AntineoplasticOrganoplatinum CompoundsDose-Response Relationship, DrugInduction ChemotherapyBleomycinNeoplasm Recurrence, LocalDeoxycytidineIfosfamideAntineoplastic Agents, AlkylatingAnthracyclinesCamptothecinGeneralization, StimulusOvarian NeoplasmsReaction TimeCarcinoma, Non-Small-Cell LungAcoustic StimulationCytarabineAdenocarcinomaNeoplasm MetastasisXenograft Model Antitumor AssaysCell SurvivalFollow-Up StudiesChemotherapy, Cancer, Regional PerfusionSalvage TherapyClinical Trials as TopicMice, NudeCell ProliferationColorectal NeoplasmsVomitingVisual PerceptionDiscrimination LearningTesticular NeoplasmsNeutropeniaPhysical StimulationMitomycinNauseaTumor Cells, CulturedLymphoma, Non-HodgkinTransplantation, AutologousPlatinum CompoundsMitoxantroneDiscrimination (Psychology)DacarbazineDaunorubicinDrug SynergismBrain NeoplasmsRadiotherapy, AdjuvantCarmustineLiver NeoplasmsHodgkin DiseaseRadiotherapyDrug Delivery SystemsOsteosarcomaPattern Recognition, VisualProspective StudiesBone NeoplasmsInhibitory Concentration 50AttentionPsychophysicsTumor Markers, BiologicalPlatinumMelphalanColonic NeoplasmsSignal TransductionKaplan-Meier EstimateInfusions, Intra-ArterialNeoplasms, Germ Cell and EmbryonalSensory Thresholds